2025. Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release. Journal of Carcinogenesis. 24, 7s (Sep. 2025), 866–877. DOI:https://doi.org/10.64149/J.Carcinog.24.7s.866-877.